Rising occurrence of cancer, advancements in NGS platforms, diminishing costs of genome sequencing and growing applications of NGS in cancer, improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, growing incidence of cancer, and increasing applications of next-generation sequencing in cancer research are the key factors that impel the escalation of the market.
Interpretation of complex data from NGS platforms, Ethical issues, Introduction of alternative technologies, the developing counties research & development mainly depends upon external funding. Budget constraints in developing countries are the main cause to resist the expansion of the market.
The applications of molecular diagnostics, NGS in personalized medicine, and government hold for huge level sequencing create vast opportunities for the players in this market.
The sequencing by synthesis segment, NGS consumables segment, diagnostics segment, academic institutes & research centers segment dominates the biggest share of the market; from the Product & Service, Technology, Application, and End-User segments respectively.
North America dominates the major shares of the Next-generation Sequencing (NGS) Market; it is due to the growing applications of NGS in diagnostics, genomic research, and accessibility to research funding.
The global Next-generation Sequencing (NGS) Market study provides market data by the competitive landscape, revenue analysis, market segments, and detailed analysis of key market players such as;
SPER Market Research study aims to provide market dynamics, demand, and supply with a yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product segment- NGS Consumables, Sequencing Services (Exome & Targeted Resequencing & Custom Panels, Whole-Genome Sequencing & De Novo Sequencing, RNA Sequencing, Other Sequencing Services), Presequencing Products & Services (Library Preparation & Target Enrichment, Quality Control), NGS Platforms (Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, Other Platforms),Bioinformatics(Data Analysis Services, NGS Data Analysis Software & Workbenches, NGS Storage, Management, & Cloud Computing Solutions), Services for NGS Platforms; for Technology segment- ION Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis, Single-Molecule Real-Time Sequencing; for Application segment- Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications), Drug Discovery, Agricultural & Animal Research, Other Applications; for End-user segment- Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific, and the Rest of the World.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.